Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system

Brain Research

Volumn 764, Issue 1-2, 1997, Pages 81-92

  Stornetta, Ruth L ^a   Grubb, Michele C ^a   Guyenet, Patrice G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

2 Adrenergic receptor; Atipamezole; c Fos; Catecholamine; Locus coeruleus; Rostral ventrolateral medulla; Withdrawal

Indexed keywords

ATIPAMEZOLE; CLONIDINE; NALTREXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE INDUCTION; LOCUS CERULEUS; MEAN ARTERIAL PRESSURE; NONHUMAN; ONCOGENE C FOS; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SPINAL CORD VENTRAL HORN; THALAMUS VENTRAL NUCLEUS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; CLONIDINE; DRUG IMPLANTS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 0030821573     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00424-1     Document Type: Article

References (55)

1. G.K. Aghajanian, Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors, J. Clin. Psychiat. 43 (1982) 20-24.
2. G.K. Aghajanian, J.H. Kogan, B. Moghaddam, Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res. 636 (1994) 126-130.
3. M. Asanuma, N. Ogawa, Pitfalls in assessment of c-fos mrna expression in the brain: effects of animal handling [review], Rev. Neurosci. 5 (1994) 171-178.
4. J. Atkinson, L. Lambas-Senas, M. Parker, N. Boillat, P. Luthi, M. Sonnay, M. Seccia, B. Renaud, Chronic clonidine treatment and its withdrawal: effects on blood pressure and catecholamine synthesizing enzymes in brain-stem nuclei, Eur. J. Pharmacol. 121 (1986) 97-106.
5. S.C. Baraban, R.L. Stornetta, P.G. Guyenet, Effects of morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla, Brain Res. 676 (1995) 245-257.
6. J.J. Buccafusco, C.A. Lapp, K.L. Westbrooks, P. Ernsberger, Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats, J. Pharmacol. Exp. Ther. 273 (1995) 1162-1171.
7. R.A. Dampney, Y.W. Li, Y. Hirooka, P. Potts, J.W. Polson, Use of c-fos functional mapping to identify the central baroreceptor reflex pathway: advantages and limitations [review], Clin. Exp. Hypertens. 17 (1995) 197-208.
8. H. De Vos, G. Bricca, J. De Keyser, J.P. De Backer, P. Bousquet, G. Vauquelin, Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system, Neuroscience 59 (1994) 589-598.
9. P. DiStefano, G. Fox, E.M. Johnson Jr., Characterization of the clonidine withdrawal syndrome in the normotensive rat, J. Pharmacol. Exp. Ther. 214 (1980) 263-268.
10. R.K. Dix, E.M. Johnson Jr., Withdrawal syndrome upon cessation of chronic clonidine treatment in rats, Eur. J. Pharmacol. 44 (1977) 153-159.
11. S. Duggan, M. Hong, B. Milne, K. Jhamandas, The role of excitatory amino acids in the expression of precipitated acute and chronic clonidine withdrawal: an in vivo voltammetric study in the rat locus coeruleus, Brain Res. 665 (1994) 253-261.
12. G. Engberg, M. Elam, T.H. Svensson, Clonidine withdrawal: activation of brain noradrenergic neurons with specifically reduced alpha 2-receptor sensitivity, Life Sci. 30 (1982) 235-243.
13. G.G. Geyskes, P. Boer, E.J. Dorhout Mees, Clonidine withdrawal. Mechanism and frequency of rebound hypertension, Br. J. Clin. Pharmacol. 7 (1979) 55-62.
14. X. Guitart, E.J. Nestler, Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus [review], Neurochem. Res. 18 (1993) 5-13.
15. P.G. Guyenet, N. Koshiya, D.H. Huangfu, S.C. Baraban, R.L. Stornetta, Y.-W. Li, Role of medulla oblongata in generation of sympathetic and vagal outflows, Prog. Brain Res. 107 (1996) 127-144.
16. B.G. Hansson, B. Hokfelt, Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine, Br. J. Clin. Pharmacol. 11 (1981) 73-77.
17. 2-adrenergic receptors, Mol. Pharmacol. 40 (1991) 407-412.
18. M.D. Hayward, R.S. Duman, E.J. Nestler, Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain, Brain Res. 525 (1990) 256-266.
19. J.P. Hieble, D.C. Kolpak, Mediation of the hypotensive action of systemic clonidine in the rat by alpha 2-adrenoceptors, Br. J. Pharmacol. 110 (1993) 1635-1639.
20. J.P. Hieble, R.R. Ruffolo, Possible structural and functional relationships between imidazoline receptors and alpha-2 adrenoceptors. In D.J. Reis, P. Bousquet, P. Parini (Eds.) The Imidazloline Receptor: Pharmacology, Functions, Ligands and Relevance to Biology and Medicine, Ann. NY Acad. Sci., New York (1995) pp. 8-21.
21. M. Hong, S. Duggan, B. Milne, K. Jhamandas, Activation of locus coeruleus during clonidine withdrawal: an in vivo voltammetric study in the rat locus coeruleus, Soc. Neurosci. Abstr. 18 (1992).
22. B. Jarrott, S.J. Lewis, Discontinuation syndrome in rats chronically treated with centrally acting alpha-adrenoceptor agonists, Trends Pharmacol. Sci. 8 (1987) 244-246.
23. F.A. Jonkman, P.W. Man, M.J. Thoolen, P.A. Van Zwieten, Location of the mechanism of the clonidine withdrawal tachycardia in rats, J. Pharm. Pharmacol. 37 (1985) 580-582.
24. L. Lambas-Senas, J. Atkinson, J.-P. Fluckiger, M. Sonnay, G. Chamba, B. Renaud, Biochemical evidence that brainstem adrenaline-containing neurons are activated during clonidine withdrawal in the spontaneously hypertensive rat, Naunyn-Schmied. Arch. Pharmacol. 338 (5) (1988) 543-547.
25. H.Y. Li, A. Ericsson, P.E. Sawchenko, Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms, Proc. Natl. Acad. Sci. USA 93 (1996) 2359-2364.
26. A.D. Loewy, Central Autonomie Pathways. In A.D. Loewy and K.M. Spyer (Eds.) Central Regulation of Autonomie Functions, Oxford University Press, New York (1990) pp. 88-103.
27. L.B. MacMillan, L. Hein, M.S. Smith, M.T. Piascik, L.E. Limbird, Central hypotensive effects of the alpha2a-adrenergic receptor subtype, Science 273 (1996) 801-803.
28. R. Maldonado, Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence, Neurosci. Biobehav. Rev. 21 (1997) 91-104.
29. A. Moriwaki, J.B. Wang, A. Svingos, E. van Bockstaele, P. Cheng, V.M. Pickel, G.R. Uhl, μ Opiate receptor immunoreactivity in rat central nervous system, Neurochem. Res. 21 (1996) 1315-1331.
30. T. Naruse, T. Ishida, R. Ishii, T. Tagawa, K. Namba, Relationship between hypotensive effects and plasma concentrations of clonidine in spontaneously hypertensive rats: continuous treatment and sudden termination of clonidine infusion, Gen. Pharmacol. 25 (1994) 1421-1425.
31. E.J. Nestler, J.J. Erdos, R. Terwilliger, R.S. Duman, J.S. Tallman, Regulation of G proteins by chronic morphine in the rat locus coeruleus, Brain Res. 476 (2) (1989) 230-239.
32. E.J. Nestler, R. Terwilliger, D. Beitner, Regulation by chronic clonidine of adenylate cyclase and cyclic AMP-dependent protein kinase in the rat locus coeruleus, Life Sci. 45 (1989) 1073-1080.
33. K. Pacak, M. Palkovits, I.J. Kopin, D.S. Goldstein, Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies [review], Front. Neuroendocrinol. 16 (1995) 89-150.
34. M. Palkovits, J.S. Baffi, S. Dvori, Neuronal organization of stress response. Pain-induced c-fos expression in brain stem catecholaminergic cell groups, Ann. NY Acad. Sci. 771 (1995) 313-326.
35. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney (1986).
36. D.H. Penning, K. Jhamandas, Yohimbine-precipitated clonidine withdrawal: an experimental model of the antihypertensive drug withdrawal syndrome, Can. J. Physiol. Pharmacol. 70 (1992) 853-858.
37. M.A. Pezzone, W.S. Lee, G.E. Hoffman, K.M. Pezzone, B.S. Rabin, Activation of brainstem catecholaminergic neurons by conditioned and unconditioned aversive stimuli as revealed by c-fos immunoreactivity, Brain Res. 608 (1993) 310-318.
38. C.V. Ram, K. Engelman, Abrupt discontinuation of clonidine therapy, JAMA 242 (1979) 2104-2105.
39. K. Rasmussen, G.K. Aghajanian, Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis, Brain Res. 505 (1989) 346-350.
40. K. Rasmussen, D.B. Beitner-Johnson, J.H. Krystal, G.K. Aghajanian, E.J. Nestler, Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci. 10 (1990) 2308-2317.
41. J.L. Reid, B.C. Campbell, C.A. Hamilton, Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists, Hypertension 6 (1984) II71-II75.
42. 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system, J. Comp. Neurol. 372 (1996) 135-165.
43. 2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat, Neuroscience 56 (1993) 139-155.
44. H. Scheinin, E. MacDonald, M. Scheinin, Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist, Eur. J. Pharmacol. 151 (1988) 35-42.
45. 3H]atipamezole as a radioligand for alpha 2-adrenoceptors, Eur. J. Pharmacol. 215 (1992) 109-117.
46. R.L. Stornetta, M. Fisher, P.G. Guyenet, Autonomie structures in rat brain show increased numbers of c-fos positive cells during clonidine withdrawal (Abstract), Soc. Neurosci. Abstr. 20 (1994).
47. R.L. Stornetta, F.E. Norton, P.G. Guyenet, Autonomie areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats, Brain Res. 624 (1993) 19-28.
48. E.M. Talley, D.L. Rosin, A. Lee, P.G. Guyenet, K.R. Lynch, Distribution of alpha(2a)-adrenergic receptor-like immunoreactivity in the rat central nervous system, J. Comp. Neurol. 372 (1996) 111-134.
49. M.J. Thoolen, P.B. Timmermans, P.A. Van Zwieten, Withdrawal syndrome after continuous infusion of clonidine in the normotensive rat, J. Pharm. Pharmacol. 33 (1981) 232-235.
50. M.J. Thoolen, P.B. Timmermans, P.A. Van Zwieten, The clonidine withdrawal syndrome. Its reproduction and evaluation in laboratory animal models [Review], Gen. Pharmacol. 12 (1981) 303-308.
51. M.J.M.C. Thoolen, P.B.M.W.M. Timmermans, P.A. Van Zwieten, Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat, Naunyn-Schmied. Arch. Pharm. 319 (1982) 82-86.
52. E.J. Van Bockstaele, E.E.O. Colago, P. Cheng, A. Moriwaki, G.R. Uhl, V.M. Pickel, Ultrastructural evidence for prominent distribution of the μ-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus, J. Neurosci. 16 (1996) 5037-5048.
53. P.A. Van Zwieten, J.P. Chalmers, Different types of centrally acting antihypertensives and their targets in the central nervous system [review], Cardiovasc. Drugs Ther. 8 (1994) 787-799.
54. P.A. VanZweiten, Antihypertensive drugs interacting with the sympathetic nervous system and its receptors. In M.J. Antonaccio (Ed.) Cardiovasc. Pharmacol., 3rd edn., Raven, New York (1990) pp. 37-73.
55. R. Virtanen, J.M. Savola, V. Saano, Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole, Arch. Int. Pharm. Ther. 297 (1989) 190-204.